...Morning, everyone. Thank you for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and really pleased to be joined by the Regeneron team. Next to me is Chris Fenimore, Head of Finance and CFO; and Ryan Crowe, Head of IR and Strategic Analysis. So to start here, actually, Ryan, let me turn it over to you, because I can give some opening comments. Ryan Crowe ...